Life Science Innovation Network Japan (LINK-J) boldly launched the partnering event series “Advanced Therapy Showcase in Tokyo (ATST)” with its first edition successfully held back in January 2021. Now we are pleased to announce that the second edition of the series, the ATST#2, is going to be held on Friday, January 28, 2022.The ATST#2 features live-streaming company presentations and pre-arranged 1-on-1 business partnering Meetings.The event will be fully virtual.Any entities or individuals engaged in the field of advanced therapy including but not limited to cell & gene therapy, regenerative medicine, nucleic acid therapy, etc., are encouraged to participate in this event to find suitable and relevant partner candidates for their business endeavors.
Date and Time:
January 28, 2022 8:00～12:00 17:00～20:00（TBD）
Venue:
Online
Registration
(Opens an external site)
Official language：English Held in Combination The 6th Industry Academic Government Symposium on Regenerative Medicine ※Official Language Japanese
Program
| Time | Program |
| 8:00 |
Opening Remarks by Hideyuki Okano, M.D., Ph.D. (Chairman of the Board, LINK-J) |
| 8:05 |
Keynotes by Michael Lehmicke, MSc（Director, Science & Industry Affairs, The Alliance for Regenerative Medicine (ARM)） |
| 8:25- |
Live-streaming company presentation Participating companies |
| 12:35- |
Break (including The 6th Industry Academic Government Symposium on Regenerative Medicine) |
| 17:00- |
Keynote by Philippe Fauchet Owen Smith（4Bio Capital） |
| 17:20- |
Live-streaming company presentation Participating companies |
The detailed program can be found here
Live-Streaming Presenters
Inteligex, Inc.
EpiBone, Inc.
ProgeniCyte
DiscGenics, Inc.
RepliCel Life Sciences Inc.
NeuroSyntek Modeling and Manufacturing, Inc.
Celaid Therapeutics Inc.
CellFiber Co.,Ltd.
GenScript Japan Inc.
Jiksak Bioengineering, Inc.
Oncolys BioPharma Inc.
PuREC Co., Ltd.
TerumoBCT, Inc.
Cellatoz Therapeutics, Inc.
HaplnScience Inc.
Helixmith Co., Ltd.
GenomeFrontier Therapeutics, Inc.
Stempeutics Research Pvt. Ltd.
PDC*Line Pharma SA
Defymed SAS
Eligo Biosicience SAS
TreeFrog Therapeutics SA
Amniotics AB
Touchlight Genetics Ltd.
Salipro Biotech AB
Target
Product developers, novel technology providers, platform developers, and researchers who seek partners in Japan or elsewhere, and crave to excel in the field of advanced therapies such as;Any parties who are interested in partnering with product developers, novel technology providers, platform developers, and researchers who seek partners in Japan or elsewhere, and crave to excel in the field of advanced therapies such as;
- regenerative medicine and tissue engineering,
- cell therapy and gene-modified cell therapy,
- gene therapy (in vivo/ex vivo) and gene editing therapy,
- exosome based therapy,
- nucleic acid medicine,
- stem cell based drug discovery, etc.
Participation fee
Free
Registration deadline
January 27, 2022（JST）
Organizer
LINK-J
Event Supporters
 |
 |
 |
| American Chambers of Commerce in Japan (ACCJ) | Alliance for Regenerative Medicine(ARM) | BIOCOM |
 |
 |
 |
| BIOWIN | Centre for Commercialization of Regenerative Medicine(CCRM) | Forum for Innovative Regenerative Medicine (FIRM) |
 |
 |
 |
| Foundation for Biomedical Research and Innovation at Kobe（FBRI） | 4BIO Capital | Institute for Advanced Biosciences, Keio University |
 |
 |
 |
| Japan External Trade Organization （JETRO） | The Japanese Society for Regenerative Medicine | Kanagawa |
 |
 |
 |
| Kawasaki | Kyoto Research Park Corp. | Osaka |
 |
||
| Yokohama |
Contact
LINK-J
E-mail：atst@link-j.org
